AXT
AXT's revenue fell 11.1% to $88 million in fiscal 2025. Its operating margin was −24.9%, down from −14.9% a year earlier. Free cash flow was −$19 million. The diluted share count rose 1.8%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What AXT does
AXT makes wafers, called substrates, that serve as the base layer for chips that cannot use ordinary silicon. It says it does not design or make the chips themselves. It has two product lines: specialty material substrates and the raw materials used to make them.
Its substrates are made from indium phosphide, gallium arsenide and germanium. Indium phosphide goes into fiber optic and 5G equipment and data center connections, where the company says AI is raising the need for fast data transfer. Gallium arsenide goes into phone power amplifiers, satellite communications, LEDs and lasers. Germanium goes into solar cells for space and ground use.
Some of AXT's consolidated subsidiaries make raw materials, such as boron nitride crucibles used to grow crystals and purified gallium. It uses these in its own production and also sells them to other companies. Its customers are chip makers, and it names loss of its top-tier substrate customers as a significant risk.
Its biggest risks, as it describes them
- Trade tariffs and export limits, such as China's requirement of export permits for indium phosphide.
- Losing one or more of its tier one substrate customers.
- Silicon wafers, which cost much less, replacing specialty materials in some uses.
- Falling selling prices and a gross margin that has varied and may decline.
- Strong competition from rivals that may develop better products.
Income statement
From fiscal 2016 to 2022, earnings per share grew 13.8% a year and net income 18.9% a year, as new shares raised the share count by 30% and diluted each share's earnings. AXT then lost money in fiscal 2023, 2024 and 2025.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 42 | 44 | 40 | 23 | 120 |
| Debt incl. finance leases | — | — | — | — | — |
| Net debt (negative means net cash) | — | — | — | — | — |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | — | — | — | — | — |
| Interest coverage | — | — | −14.1x | −11.1x | −17.5x |
| Current ratio | 3.4x | 2.4x | 2.1x | 2.1x | 2.7x |
| Quick ratio | 2.0x | 1.2x | 1.0x | 1.0x | 1.8x |
Cash flow
Projections
Project AXT's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 7, 2025 and November 6, 2026, no insider bought AXT shares on the open market, and 5 insiders sold $76.3 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Leonard J LeblancDirector | Sold | 4,000 | $96.07 | $384,280 | Form 4 |
| Aug 7, 2026 | Leonard J LeblancDirector | Sold | 2,000 | $88.32 | $176,640 | Form 4 |
| Jun 15, 2026 | David C ChangDirector | Sold | 8,333 | $111.17 | $926,380 | Form 4 |
| Jun 15, 2026 | Jesse ChenDirector | Sold | 6,172 | $115.24 | $711,261 | Form 4 |
| Jun 12, 2026 | Jesse ChenDirector | Sold | 13,000 | $95.77 | $1.2 million | Form 4 |
| Jun 11, 2026 | Jesse ChenDirector | Sold | 9,000 | $88.55 | $796,950 | Form 4 |
| Jun 10, 2026 | Jesse ChenDirector | Sold | 9,000 | $86.73 | $780,570 | Form 4 |
| Jun 10, 2026 | Leonard J LeblancDirector | Sold | 500 | $89.59 | $44,795 | Form 4 |
| Jun 9, 2026 | Jesse ChenDirector | Sold | 1,500 | $93.30 | $139,950 | Form 4 |
| Jun 8, 2026 | Jesse ChenDirector | Sold | 6,000 | $94.00 | $564,000 | Form 4 |
| Jun 4, 2026 | Jesse ChenDirector | Sold | 6,133 | $108.28 | $664,081 | Form 4 |
| Jun 3, 2026 | Jesse ChenDirector | Sold | 4,000 | $111.36 | $445,440 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | −55.6% | 13.1% | −32.4% |
| Altman Z'' | 3.60 | 3.60 | 4.67 |
| Accruals ratio | −5.8% | 0.1% | −2.2% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Pass | Fail | Fail |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Fail | Pass |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | Fail | Pass | Pass |
| Share count didn't rise | Pass | Fail | Fail |
| Gross margin rose | Fail | Pass | Fail |
| Revenue rose relative to assets | Fail | Pass | Fail |
| F-score | — | — | — |
Compare
Put AXT side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| AXT | FY25 | −11.1% | −24.9% | −21.3% | — | — | — | |
| Aehr Test Systems | FY26 | −15.2% | −28.3% | −10.8% | −11.1% | — | 2 | Compare |
| PDF Solutions | FY25 | 22.0% | 2.7% | −3.9% | 1.4% | 2.5x | 4 | Compare |
| Cohu | FY25 | 12.7% | −15.4% | 2.4% | −9.1% | — | 5 | Compare |
| Kulicke and Soffa Industries | FY25 | −7.4% | −0.5% | 14.7% | — | — | — | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 81 | 99 | 102 | 83 | 95 | 137 | 141 | 76 | 99 | 88 |
| Revenue growth | 5.0% | 21.3% | 3.8% | −18.7% | 14.5% | 44.1% | 2.7% | −46.3% | 31.1% | −11.1% |
| Gross profit | 26 | 34 | 37 | 25 | 30 | 47 | 52 | 13 | 24 | 11 |
| Research and development | 6 | 5 | 6 | 6 | 7 | 10 | 14 | 12 | 14 | 9 |
| Operating income | 6 | 13 | 12 | −0 | 4 | 13 | 13 | −22 | −15 | −22 |
| Net income | 6 | 10 | 10 | −3 | 3 | 15 | 16 | −18 | −12 | −21 |
| Diluted EPS (US$) | 0.17 | 0.26 | 0.24 | −0.07 | 0.07 | 0.34 | 0.37 | −0.42 | −0.27 | −0.49 |
| Diluted shares (millions) | 33 | 39 | 40 | 40 | 41 | 43 | 43 | 43 | 43 | 44 |
| Cash flow | ||||||||||
| Cash from operations | 12 | 9 | 3 | 13 | 6 | −3 | −9 | 3 | −12 | −13 |
| Capital expenditure | 3 | 21 | 40 | 22 | 20 | 30 | 28 | 10 | 6 | 6 |
| Free cash flow | 10 | −13 | −37 | −9 | −14 | −33 | −37 | −7 | −18 | −19 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 1 | 1 | 2 | 2 | 3 | 4 | 4 | 4 | 3 | 3 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 48 | 64 | 39 | 36 | 73 | 42 | 44 | 40 | 23 | 120 |
| Debt incl. finance leases | — | — | — | — | — | — | — | — | — | — |
| Total assets | 154 | 211 | 224 | 223 | 299 | 332 | 370 | 359 | 339 | 434 |
| Total liabilities | 17 | 23 | 29 | 31 | 43 | 52 | 80 | 90 | 84 | 99 |
| Shareholders' equity | 133 | 184 | 191 | 188 | 193 | 212 | 222 | 204 | 193 | 273 |
| Margins and ratios | ||||||||||
| Gross margin | 32.4% | 34.9% | 36.2% | 29.8% | 31.8% | 34.5% | 36.9% | 17.6% | 24.0% | 12.7% |
| Operating margin | 7.9% | 12.8% | 11.9% | −0.4% | 4.1% | 9.4% | 8.9% | −28.5% | −14.9% | −24.9% |
| Net margin | 6.9% | 10.3% | 9.4% | −3.1% | 3.4% | 10.6% | 11.2% | −23.6% | −11.7% | −24.1% |
| Free cash flow margin | 12.0% | −12.9% | −36.5% | −11.0% | −14.7% | −24.0% | −26.4% | −9.3% | −18.0% | −21.3% |
| Rule of 40 (growth + FCF margin) | 17.0% | 8.4% | −32.7% | −29.7% | −0.1% | 20.1% | −23.7% | −55.6% | 13.1% | −32.4% |
| Return on capital | — | — | — | — | — | — | — | — | — | — |
| Return on equity | 4.2% | 6.4% | 5.2% | −1.4% | 1.7% | 7.2% | 7.3% | −8.4% | −5.9% | −9.1% |
| Return on assets | 3.7% | 5.5% | 4.4% | −1.2% | 1.2% | 4.6% | 4.5% | −4.9% | −3.3% | −5.5% |
| Net debt to EBITDA | — | — | — | — | — | — | — | — | — | — |